marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
.
.
.
february 2005 (8)
.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
worried about how helen was doing after doctors performed surgery on her colon the same day he was admitted, robert, whose condition stabilized, had a simple request for his nurse:
.
orchid pharma faces liquidation as lenders reject resolution plan